Seidel, AngelaLi, MichaelLalonde, Karl-AndreShorr, RisaMeulenkamp, Bradley2025-12-022025-12-022025-11-26BMC Musculoskeletal Disorders. 2025 Nov 26;26(1):1071https://doi.org/10.1186/s12891-025-09278-4http://hdl.handle.net/10393/51125Abstract Background Following total ankle replacement (TAR), osteolysis is a known complication. No consensus exists regarding management. Methods Applying the Arksey and O’Malley framework for scoping studies, a study protocol and a data extraction form was created. The research included all studies until March 2025. Study selection and data extraction were performed by two independent reviewers. Results Two hundred and eighty-seven studies were identified, of which 54 studies (case series and case reports) were included. 69% of the studies included below 10 cases. The most common reported treatment was bone grafting in n = 36 (67%) of studies. The conversion of the TAR to an ankle fusion (n = 16 studies, 30%) was more frequent than the revision to a TAR (n = 15 studies, 28%). Eleven studies reported multiple treatment options. Long-term follow-up and standardized outcome measurements were infrequently discussed. Conclusion This scoping review demonstrates that the existing literature is highly heterogeneous and insufficient to recommend standard treatment.Journal Article2025-12-02enThe Author(s)